ARTICLE | Distillery Therapeutics
Cancer
October 17, 2017 4:56 PM UTC
Cell culture studies suggest inhibiting the polyadenylation factor CPSF1 or an alternative polyadenylation site on androgen receptor mRNA could help treat prostate cancer. In tissue samples from patie...
BCIQ Company Profiles